A Preliminary Evaluation of the Physiological Mechanisms of Action for Sleep Restriction Therapy
Table 5
Median (range) power values for responders for beta-1 and beta-2 band frequencies.
BN2
TR3
TR4
Sleep stages
Median
Range
Median
Range
Median
Range
Beta-1
Cycle 1
NRem
2.41
1.62–12.14
2.09
1.92–9.06
1.48
1.13–2.98
Rem
1.83
0.78–5.93
1.88
0.89–6.37
2.45
0.58–3.11
1
3.01
1.06–7.54
2.93
2.93-2.93
1.80
1.14–2.45
2*
4.27
2.99–13.88
3.29
2.22–11.89
3.15
1.31–5.13
3*
2.30
2.10–9.09
1.91
1.59–6.97
1.34
1.29–3.95
4
1.53
1.40–7.45
1.62
1.48–5.09
3.02
2.90–4.64
Cycle 2
NRem*
3.86
1.72–11.04
3.44
1.33–4.75
1.81
1.14–2.55
Rem
1.65
0.73–5.28
1.11
0.98–6.34
1.33
0.66–2.86
1
1.40
1.40-1.40
1.55
1.55-1.55
1.88
1.40–2.36
2
8.45
2.31–14.80
3.44
2.31–6.78
2.79
1.67–5.13
3
2.02
1.42–8.16
5.10
1.15–9.04
1.75
1.28–3.83
4
3.37
1.27–5.47
2.44
0.95–3.92
1.44
0.76–1.56
All cycles
NRem*
3.21
1.76–11.99
2.77
1.69–7.43
2.38
1.19–4.22
Rem
1.57
0.77–5.78
1.52
1.02–6.36
1.67
0.61–3.04
1
3.46
1.14–7.05
2.71
1.33–7.25
2.39
0.95–3.19
2*
3.53
2.23–14.64
3.30
2.18–10.10
3.19
1.51–5.77
3*
2.09
1.51–8.47
1.91
1.34–6.79
1.57
1.33–3.87
4
1.53
1.37–5.96
1.62
1.22–4.14
1.38
0.92–1.62
Beta-2
Cycle 1
NRem
0.75
0.56–3.27
1.01
0.92–4.08
0.51
0.51–1.10
Rem
1.13
0.86–4.01
1.04
0.89–5.29
0.98
0.60–1.64
1
1.43
0.87–5.64
1.08
1.08-1.08
1.16
0.93–1.38
2
1.25
0.89–3.13
1.39
1.31–5.82
1.19
0.66–2.09
3
0.67
0.63–2.25
0.80
0.58–2.46
0.48
0.47–1.15
4
0.56
0.50–2.17
0.84
0.59–2.48
1.18
0.96–1.61
Cycle 2
NRem*
1.78
0.67–2.51
1.00
0.47–1.89
0.67
0.42–0.93
Rem
1.11
0.79–3.24
0.95
0.84–5.70
0.86
0.53–1.55
1
1.43
1.43-1.43
1.35
1.35-1.35
1.00
0.92–1.07
2
3.01
0.75–4.51
1.00
0.78–5.43
0.70
0.55–1.41
3
0.68
0.53–2.18
1.49
0.48–2.50
0.60
0.45–1.14
4*
1.09
0.47–1.71
1.04
0.49–1.59
0.53
0.32–0.75
All cycles
NRem
1.14
0.77–3.01
0.96
0.90–2.76
0.75
0.52–1.36
Rem
1.11
0.82–3.59
1.00
0.88–5.72
0.92
0.58–1.80
1
1.39
1.25–5.09
1.27
1.15–9.01
1.06
1.03–2.78
2*
1.10
0.75–3.07
1.29
1.18–3.73
0.85
0.58–1.64
3
0.66
0.54–2.20
0.80
0.52–2.35
0.55
0.47–1.14
4
0.56
0.49–1.82
0.84
0.54–1.75
0.51
0.35–0.77
BN2: baseline night 2; TR3: the third night in lab and the first of treatment; TR4: the fourth night in lab and the second of treatment; NREM: nonrapid eye movement; REM: rapid eye movement. *Significant results at ≤ 0.05 between nights for the sleep stages targeted.
